Tigecycline
DrugBank ID: DB00560
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| disorder of tyrosine metabolism | 0.9576 | DL |
| teratogenic Pierre Robin syndrome | 0.9533 | DL |
| tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | 0.9491 | DL |
| disorder of phenylalanine metabolism | 0.9360 | DL |
| hyperamylasemia | 0.9355 | DL |
| polyclonal hyperviscosity syndrome | 0.9355 | DL |
| congenital analbuminemia | 0.9284 | DL |
| blood group incompatibility | 0.9194 | DL |
| premalignant hematological system disease | 0.9175 | DL |
| monoclonal gammopathy | 0.9087 | DL |
| hematological disease associated with an acquired peripheral neuropathy | 0.9025 | DL |
| pyelonephritis | 0.9005 | DL |
| congenital hematological disorder | 0.8902 | DL |
| septicemic plague | 0.8814 | DL |
| streptococcal pneumonia | 0.8804 | DL |
| neonatal epileptic encephalopathy due to glutaminase deficiency | 0.8490 | DL |
| idiopathic bilateral vestibulopathy | 0.8479 | DL |
| semicircular canal dehiscence syndrome | 0.8479 | DL |
| genetic otorhinolaryngological malformation | 0.8465 | DL |
| inborn disorder of phenylalanin or tyrosine metabolism | 0.8448 | DL |
| pleural adenomatoid tumor | 0.8426 | DL |
| hematopoietic and lymphoid system neoplasm | 0.8414 | DL |
| juvenile nasopharyngeal angiofibroma (disease) | 0.8368 | DL |
| pleural epithelioid mesothelioma | 0.8341 | DL |
| pleural biphasic mesothelioma | 0.8340 | DL |
| cystitis | 0.8337 | DL |
| propylthiouracil embryofetopathy | 0.8330 | DL |
| pleural sarcomatoid mesothelioma | 0.8315 | DL |
| tetrahydrobiopterin metabolic process disease | 0.8309 | DL |
| familial nasal acilia | 0.8302 | DL |
| pericardium cancer | 0.8275 | DL |
| malignant pleural mesothelioma | 0.8274 | DL |
| lymphohistiocytoid mesothelioma | 0.8245 | DL |
| silent sinus syndrome | 0.8243 | DL |
| well differentiated papillary mesothelioma | 0.8209 | DL |
| pleural mesothelioma | 0.8184 | DL |
| maternal disease-related embryofetopathy | 0.8169 | DL |
| Plasmodium falciparum malaria | 0.8149 | DL |
| malignant epithelioid mesothelioma | 0.8147 | DL |
| malignant peritoneal mesothelioma | 0.8063 | DL |
| sarcomatoid mesothelioma | 0.8056 | DL |
| cleft lip/palate-intestinal malrotation-cardiopathy syndrome | 0.8054 | DL |
| indomethacin embryofetopathy | 0.8039 | DL |
| branchial cleft anomaly | 0.8035 | DL |
| fetal minoxidil syndrome | 0.8033 | DL |
| maternal hyperthermia induced birth defects | 0.8005 | DL |
| staphylococcus aureus infection | 0.7986 | DL |
| craniorhiny | 0.7985 | DL |
| phenobarbital embryopathy | 0.7981 | DL |
| malignant visceral pleura tumor | 0.7976 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.